Fascioliasis Treatment Market to Witness Unprecedented Growth

  • 30 Apr 2019

Infections in humans and cattle due to food-borne parasites are widespread across the globe. Fascioliasis or liver fluke infection is prevalent amongst children, cattle and sheep in rural livestock rearing parts of the world like Peru, Vietnam, Bolivia, Egypt, Ecuador and Iran. The only way to intercept the transmission of Fascioliasis in endemic areas is through WHO (World Health Organisation) suggested anti-fascioliasis drugs like Triclabendazole. However, resistance to this WHO recommended drug and toxicity dangers associated with hexachloro-para-xylol, emetine, niclofolan, chloroquine, etc. has opened doors to the discovery of alternative medicines like Nitazoxanide. 
 

Furthermore, fascioliasis interfered with chronic conditions like ascending cholangitis are a challenge as they need appropriate antibacterial antibiotics. Thus in accordance with combat against the adverse consequences on public health and eventually socio-economic progress pharmaceutical companies are striving to provide a viable solution to neglected tropical disease.
With the support from WHO and government bodies, global fascioliasis treatment market players can gain critical missing information about unsafe food that can help in drug innovation for Fascioliasis treatment. The research experts at FutureWise predicted a robust CAGR for the global fascioliasis treatment market during the forecast period 2019-2026.

 

Global Fascioliasis Treatment Market, by Treatment Type
•    Standard Therapy
•    Supportive Therapy
At present standard therapy holds the major global fascioliasis treatment market as significant dosage complications and temporary post-treatment side effects are issues better handled by standard therapy. The R&D efforts and investments for suitable standard drug discovery are estimated to augment standard therapy segment in the upcoming period. Also, WHO initiatives and support to provide free of cost drug in developing nations of endemic regions are to affect the growth of the market.

 

Global Fascioliasis Treatment Market, by End-User
•    Hospitals
•    Clinics
•    Personalised cares

Global Fascioliasis Treatment Market, by Region
•    North America
•    Latin America
•    Europe
•    Asia Pacific
•    Rest of the World
Due to stringent sanitation policies and high food quality standards, North America and Europe are to experience negligible CAGR in the near future. The high dependency on animal food sources, lack of awareness about hazards of raw vegetables and meat consumption and insufficient measures to curb the epidemic are factors that would triumph the robust CAGR in APAC and Latin America region.


Competitive Landscape:  
•    Tier 1 players- established companies in the market with a major    market share
•    Tier 2 players 
•    Emerging players which are growing rapidly 
•    New Entrants  

 

FutureWise Key Takeaways 
•    Growth prospects
•    SWOT analysis 
•    Key trends 
•    Key data-points affecting market growth 

 

Objectives of the Study: 
•    To provide with an exhaustive analysis on the global fascioliasis treatment market on the basis of treatment type, distribution channel, and region
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East
•    To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
•    Profiling of companies to evaluate their market shares, strategies, financials and core competencies  

 

Get unlimited analyst support and customise this study further to your requirements, contact [email protected]